International Clinical Trial: Paclitaxel Cationic Liposome (Hepatic Arterial Infusion) in Combination With Systemic Therapy as First-Line Treatment in Colorectal Liver Metastases

Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07117435) titled 'Paclitaxel Cationic Liposome (Hepatic Arterial Infusion) in Combination With Systemic Therapy as First-Line Treatment in Colorectal Liver Metastases' on Aug. 5.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Condition: Colorectal Liver Metastases First-line Treatment

Intervention: Drug: paclitaxel cationic liposome for injection Drug: Oxaliplatin Drug: Capecitabine

Recruitment Status: Recruiting

Phase: Phase 1

Date of First Enrollm...